RIOS
Stories naming Mike Zimmerman. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Deep-tech investor Main Sequence is seeking $400 million for a fourth fund, with $75 million already committed by the federal government, after two portfolio companies reached unicorn status this year.
Main Sequence, CSIRO's deep tech venture fund, adds Cochlear chair Alison Deans as a venture partner, extending her investment committee service since 2017; its third fund brought in $450 million in July.
Deep tech venture firm Main Sequence has reached an initial A$450 million close on its third fund, pushing money under management past A$1 billion; Hostplus, Temasek and CSIRO are among the backers.
Also SmartCompany·SmartCompany·Startup Daily·SmartCompany·Startup Daily·Startup Daily·@AuManufacturing·Business News Australia·TechCrunch Venture
Australian microbial carbon-removal startup Loam Bio raised a $40 million Series A led by TIME Ventures, with CEFC, Main Sequence, Horizons Ventures and others joining; Virescent Ventures says it has invested $5.8 million.
Also Startup Daily·AgFunderNews·SmartCompany·Cut Through Venture·@AuManufacturing·Forbes Australia·Forbes Australia
Main Sequence announces Australian Ethical has joined its second fund as a strategic backer, pairing ethical capital with deep tech investing to address challenges across health, food, space and industrial productivity.
Australia's Main Sequence has pulled in A$250 million for its second deep tech fund, with existing backers returning and a sharpened emphasis on decarbonisation investments.
Also TechCrunch Venture·TechCrunch Venture·SmartCompany·@AuManufacturing·Startup Daily·SmartCompany·TechCrunch Venture
Interview with Main Sequence Ventures partner Mike Zimmerman on backing deep-tech manufacturing spinouts from public research, its portfolio, Australia's venture market, and planned future investments.
Security startup Kasada has banked fresh capital from Main Sequence Ventures and Reinventure to drive American expansion, reporting rapid revenue gains; an earlier round involving Our Innovation Fund is also noted.